Insulet Corporation’s PODD rapid progress with its strategic imperatives on Omnipod platform is poised to help it grow in the upcoming quarters. The largely untapped diabetes market also presents ...
DexCom Inc (DXCM) stock saw a decline, ending the day at $77.72 which represents a decrease of $-1.20 or -1.52% from the prior close of $78.92. The stock opened at $79.21 and touched a low of $77.33 ...
DexCom Inc (DXCM) stock saw a decline, ending the day at $78.92 which represents a decrease of $-2.09 or -2.58% from the prior close of $81.01. The stock opened at $80.91 and touched a low of $78.06 ...
Johnson Fistel, LLP investigates potential violations of federal and state laws by certain officers of several publicly traded companies, including DexCom, Inc.